Zacks Investment ResearchThu, 25 Jun 2026 12:51:07 GMTSilence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?SLN+9.61%
BenzingaWed, 24 Jun 2026 18:22:30 GMTThis $300 Million Biotech May Be Deeply Mispriced: AnalystSLN+9.61%
BenzingaFri, 12 Jun 2026 14:47:15 GMTSilence Therapeutics Stock Rises On Positive Blood Cancer Drug DataSLN+9.61%
Zacks Investment ResearchThu, 16 Apr 2026 13:52:15 GMTSilence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?SLN+9.61%
